These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23355106)

  • 1. Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.
    Teguh DN; Levendag PC; Ghidey W; van Montfort K; Kwa SL
    Dysphagia; 2013 Sep; 28(3):388-94. PubMed ID: 23355106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer.
    Teguh DN; Levendag PC; Noever I; Voet P; van der Est H; van Rooij P; Dumans AG; de Boer MF; van der Huls MP; Sterk W; Schmitz PI
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):711-6. PubMed ID: 19386439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
    Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
    Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
    Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Late Dysphagia for Head and Neck Cancer Survivors with Oral Gel: A Feasibility Study.
    Kaae JK; Spejlborg ML; Spork U; Bjørndal K; Eriksen JG
    Dysphagia; 2020 Apr; 35(2):231-241. PubMed ID: 31073746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy.
    Huynh TTM; Aass HCD; Falk RS; Astrup GL; Helland Å; Bjøro T; Bjordal K; Dale E; Hellebust TP; Herlofson BB; Malinen E; Kiserud CE; Osnes T; Amdal CD
    J Cancer Surviv; 2023 Aug; 17(4):1082-1093. PubMed ID: 36350483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
    van der Laan HP; Bijl HP; Steenbakkers RJ; van der Schaaf A; Chouvalova O; Vemer-van den Hoek JG; Gawryszuk A; van der Laan BF; Oosting SF; Roodenburg JL; Wopken K; Langendijk JA
    Radiother Oncol; 2015 Apr; 115(1):56-62. PubMed ID: 25792467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
    Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
    Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires.
    Steen-Olsen EB; Stormoen DR; Kristensen CA; Vogelius IR; Holländer-Mieritz C; Pappot H
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4199-4206. PubMed ID: 35357578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
    Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
    Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; Burlage FR; Koken PW; Doornaert P; Bijl HP; Chouvalova O; Leemans CR; de Bock GH; Christianen ME; van der Laan BF; Vissink A; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):86-93. PubMed ID: 21632133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships between xerostomia and dysphagia after chemoradiation of head and neck cancer.
    Eisbruch A; Terrell JE
    Head Neck; 2003 Dec; 25(12):1082; author reply 1082-3. PubMed ID: 14648868
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
    J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
    [No Abstract]   [Full Text] [Related]  

  • 16. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
    Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
    BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMRT for head and neck cancer: reducing xerostomia and dysphagia.
    Wang X; Eisbruch A
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i69-i75. PubMed ID: 27538846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.
    Guillen-Sola A; Soler NB; Marco E; Pera-Cegarra O; Foro P
    Trials; 2019 Aug; 20(1):503. PubMed ID: 31412947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Radiother Oncol; 2010 Oct; 97(1):132-5. PubMed ID: 20817288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.